Discontinuation report TEVA-VENLAFAXINE XR

Last updated on 2020-09-24 History
Report ID 124899
Drug Identification Number 02275058
Brand name TEVA-VENLAFAXINE XR
Common or Proper name VENLAFAXINE XR 150MG CAPS
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) VENLAFAXINE
Strength(s) 150MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging size 500
ATC code N06AX
ATC description ANTIDEPRESSANTS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2020-09-23
Actual discontinuation date 2020-09-23
Remaining supply date 2020-09-23
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Item is discontinued/transitioned to ACT product
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v2 2020-09-24 French Compare
v1 2020-09-24 English Compare